Related Experiment Video
Updated: May 27, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients
Alicia Gómez-López1, Emilio Cendejas-Bueno, Isabel Cuesta
1Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain. aliciagl@isciii.es
Abstract:
In this study we present the results of a therapeutic drug monitoring retrospective analysis involving 14 patients with several underlying diseases who were receiving voriconazole for the treatment of fungal infections. A simple high performance liquid chromatography assay with ultraviolet detection was used in the drug monitoring. We report here that serum concentrations were highly variable and unpredictable in most patients. We also found that lack of response was more frequent in patients with levels persistently lower than 1 mg/l. The number of samples with voriconazole concentrations below 1 mg/l was significantly higher in patients who exhibited therapeutic failures (88% versus 27%; P < 0.001). In addition, the period of time in which voriconazole concentrations were maintained below 1 mg/l was slightly higher in patients in the failure group. We suggest that serum concentration should be individually quantified for patients receiving voriconazole therapy. Further prospective studies are needed to clarify the potential benefit of the individualization of treatment.
Related Concept Videos
Drug Concentrations: Measurements
Plasma —...
Bioavailability Study Design: Healthy Subjects Versus Patients
Therapeutic Drug Monitoring: Drug Analysis Methods
Bioavailability Study Design: Single Versus Multiple Dose Studies
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Therapeutic Drug Monitoring: Affecting Factors
